Table 1.
KRAS mutation status among different age groups of patients with lung adenocarcinoma.
| Age groups | KRAS G12C | KRAS non-G12C | KRAS wildtype | All patients |
|---|---|---|---|---|
| 30-39 | 1 | 1 | 2 | |
| 40-49 | 6 | 6 | ||
| 50-59 | 4 | 6 | 18 | 28 |
| 60-69 | 10 | 9 | 62 | 81 |
| 70-79 | 11 | 17 | 64 | 92 |
| 80-89 | 5 | 16 | 40 | 61 |
| 90-100 | 1 | 5 | 6 | |
| All patients | 30 | 50 | 196 | 276 |
| Mean age | 70.3 | 73.0 | 71.0 | 71.3 |
Abbreviation: KRAS, Kirsten rat sarcoma virus gene.
The number of patients in each age group for this cohort are shown according to their KRAS mutation status (KRAS wildtype, KRAS p.G12C-mutated, or KRAS non-p.G12C-mutated). The total number of patients in each KRAS mutation status group is shown in bold. The All patients column shows the total number of patients in each age group. The mean patient age for KRAS-wildtype, KRAS p.G12C-mutated, and KRAS non-p.G12C-mutated tumors is also shown.